Advertisement
UK markets open in 1 hour 44 minutes
  • NIKKEI 225

    40,087.02
    +176.20 (+0.44%)
     
  • HANG SENG

    16,557.46
    -31.98 (-0.19%)
     
  • CRUDE OIL

    79.79
    -0.18 (-0.23%)
     
  • GOLD FUTURES

    2,090.20
    -5.50 (-0.26%)
     
  • DOW

    39,087.38
    +90.98 (+0.23%)
     
  • Bitcoin GBP

    50,162.77
    +1,313.53 (+2.69%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    16,274.94
    +183.04 (+1.14%)
     
  • UK FTSE All Share

    4,197.12
    +33.91 (+0.81%)
     

Qiagen Q3 profit down 38% but raises full-year outlook

FILE PHOTO: Health Testing company Qiagen, in Hilden

FRANKFURT (Reuters) - U.S.-German biotechnology company Qiagen NV said on Monday that its third-quarter net profit dropped 38%, but it raised its outlook for the full year.

Profit slumped in the quarter to $82 million from $133 million a year ago.

It said it was raising its outlook due to strong results in the first nine months and the outlook for the full year.

It now expects sales of $2.25 billion, up from a previous outlook for at least $2.2 billion.

Last month, The Wall Street Journal reported that California-based diagnostics company Bio-Rad Laboratories was in talks to merge with Qiagen.

(Reporting by Patricia Weiss; writing by Tom Sims; editing by Chris Reese)